LaVoieHealthScience Blog

O’Dwyer’s PR News: “The Biopharma Communications Balancing Act”

The Biopharma Communications Balancing Act

LaVoieHealthScience President and CEO, Donna LaVoie, contributed to the O’Dwyer’s PR News Magazine October issue focused on healthcare and medical public relations. Donna discusses what makes strategic communications and investor relations in biotech different from other industries. The communications function is often reliant on the entire strategic leadership team in a startup biotech. From her experience, Donna explains how nuances in biotech communications require a unique skillset to articulate a scientific and clinical/commercial story while balancing important strategic imperatives like time sensitive information and regulatory processes.

Read the full article on the O’Dwyer’s PR News website.

LaVoieHealthScience offers integrated communications in life sciences, with specializations in strategy consultinginvestor relations and corporate communications, and public relations and marketing.

Featured Event

No Events

Recent Blog Posts

A Well-Honed Message Will Give You the Edge You Need

The SARS-CoV-2 pathogen has scrambled literally everything around the world, including financial markets and the world economy.  At the same time, the biotech and pharmaceutical industries are in the spotlight as never before as nations and companies push...

15 Slides to a Powerful Corporate Presentation

As a communications agency serving the biotech, pharmaceutical, and affiliated health science industry for over 20 years, LaVoieHealthScience has developed specific guidance for clients on how to develop and deliver highly effective corporate presentations.  As a...